TransAlta Declares Dividends
December 12, 2025 18:39 ET | Source: TransAlta Corporation CALGARY, Alberta, Dec.…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…
Genesis Healthcare Remains Committed to Securing Longterm Stability
KENNETT SQUARE, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Following a court…
Criminal IP Reveals Global React2Shell RCE Exposure Across React Server Components
TORRANCE, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- In December 2025, the…
FrenchieGPT.ai Announces Official Launch of AI App for Dog Training & Puppy Care
HOUSTON, Dec. 12, 2025 (GLOBE NEWSWIRE) -- FrenchieGPT.ai today announced the official…
Silynxcom Secures Order of $3 Million for Advanced Tactical Communication Solutions to Asian Military Customer
December 12, 2025 09:12 ET | Source: Silynxcom Ltd. Order part of…
Sienna Announces Offering of $250 Million of 3.524% Series F Senior Unsecured Debentures and Redemption of C$175 Million of Series B Senior Unsecured Debentures
December 11, 2025 18:36 ET | Source: Sienna Senior Living NOT FOR…
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
December 11, 2025 18:25 ET | Source: Surgery Partners, Inc. BRENTWOOD, Tenn.,…
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec.…
